大川キャンパス

理学療法学科

DEPARTMENT OF PHYSICAL THERAPY

教員紹介

筒井 裕之

副学長
教授
筒井 裕之

  • 学位

    博士(医学)九州大学
  • 専門分野

    循環器内科学
  • 担当科目

    • 循環器内科学特論Ⅰ~Ⅳ
    • 医学特別研究Ⅰ~Ⅳ
  • 研究内容

    • ライフサイエンス
    • 循環器内科学
  • 業績・実績

    • <論文>

      • Tsutsui H, Sakamaki H, Momomura SI, Sakata Y, Kotobuki Y, Linden S, Idehara K, Nitta D. Empagliflozin cost-effectiveness analysis in Japanese heart failure with mildly reduced and preserved ejection fraction. ESC Heart Fail. 2023 Nov 15. doi: 10.1002/ehf2.14565.
      • Hosokawa K, Watanabe H, Taniguchi Y, Ikeda N, Inami T, Yasuda S, Murohara T, Hatano M, Tamura Y, Yamashita J, Tatsumi K, Tsujino I, Kobayakawa Y, Adachi S, Yaoita N, Minatsuki S, Todaka K, Fukuda K, Tsutsui H, Abe K; KABUKI Investigators. A Multicenter, Single-Blind, Randomized, Warfarin-Controlled Trial of Edoxaban in Patients With Chronic Thromboembolic Pulmonary Hypertension: KABUKI Trial. Circulation. 2023 Nov 13. doi: 10.1161/CIRCULATIONAHA.123.067528. Online ahead of print.PMID: 37956127
      • Sada M, Matsushima S, Ikeda M, Ikeda S, Okabe K, Ishikita A, Tadokoro T, Enzan N, Yamamoto T, Miyamoto HD,Tsutsui Y, Miyake R, Setoyama D, Kang D, Ide T, Tsutsui H. IFN-γ-STAT1-ERK Pathway Mediates Protective Effects of Invariant Natural Killer T Cells Against Doxorubicin-Induced Cardiomyocyte Death. JACC Basic Transl Sci. 2023 Jun 21;8(8):992-1007. doi: 10.1016/j.jacbts.2023.02.014. eCollection 2023 Aug.PMID: 37719427
      • Furusawa S, Ikeda M, Ide T, Kanamura T, Miyamoto H D, Abe K, Ishimaru K, Watanabe M, Tsutsui Y, Miyake R, Fujita S, Tohyama T, Matsushima S, Baba Y, Tsutsui H. Cardiac Autoantibodies Against Cardiac Troponin I in Post-Myocardial Infarction Heart Failure: Evaluation in a Novel Murine Model and Applications in Therapeutics. Circ Heart Fail e010347, 2023
      • Sakamoto K, Tohyama T, Ide T, Mukai Y, Enzan N, Nagata T, Ikeda M, Takase S, Nagayama T, Fujino T, Matsushima S,Tsutsui H. Efficacy of Early Catheter Ablation for Atrial Fibrillation After Admission for Heart Failure. JACC Clin Electrophysiol S2405-500X(23)00352-3, 2023
      • Tsutsui H, Albert N. M, Coats A. J. S, Anker S. D, Bayes-Genis A, Butler J, Chioncel O, Defilippi C. R, Drazner M. H, Felker G. M, Filippatos G, Fiuzat M, Ide T, Januzzi J. L. Jr, Kinugawa K, Kuwahara K, Matsue Y, Mentz R. J, Metra M, Pandey A, Rosano G, Saito Y, Sakata Y, Sato N, Seferovic P. M, Teerlink J, Yamamoto K, Yoshimura M. Natriuretic Peptides: Role in the Diagnosis and Management of Heart Failure: A scientific statement from the heart failure association of the European society of cardiology, heart failure society of America and Japanese heart failure society. J Card Fail 29(5):787-804, 2023
      • Tsutsui H, Albert N. M, Coats A. J. S, Anker S. D, Bayes-Genis A, Butler J, Chioncel O, Defilippi C. R, Drazner M. H, Felker G. M, Filippatos G, Fiuzat M, Ide T, Januzzi J. L. Jr, Kinugawa K, Kuwahara K, Matsue Y, Mentz R. J, Metra M, Pandey A, Rosano G, Saito Y, Sakata Y, Sato N, Seferovic P. M, Teerlink J, Yamamoto K, Yoshimura M. Natriuretic Peptides: role in the diagnosis and management of heart failure: A scientific statement from the heart failure association of the European society of cardiology, heart failure society of America and Japanese heart failure society. Eur J Heart Fail 25(5):616-631,2023
      • Shiraishi C, Matsumoto A, Ichihara K, Yamamoto T, Yokoyama T, Mizoo T, Hatano A, Matsumoto M, Tanaka Y, Matsuura-Suzuki E, Iwasaki S, Matsushima S, Tsutsui H, Nakayama K.I. RPL3L-containing ribosomes determine translation elongation dynamics required for cardiac function. Nat Commun 14(1):2131, 2023
      • Tadokoro T, Ikeda M, Ide T, Deguchi H, Ikeda S, Okabe K, Ishikita A, Matsushima S, Koumura T, Yamada K. I, Imai H, Tsutsui H. Mitochondria-dependent ferroptosis plays a pivotal role in doxorubicin cardiotoxicity. JCI Insight 8(6):2023
      • Enzan N, Matsushima S, Ikeda S, Okabe K, Ishikita A, Yamamoto T, Sada M, Miyake R, Tsutsui Y, Nishimura R, Toyohara T, Ikeda Y, Shojima Y, Miyamoto H. D, Tadokoro T, Ikeda M, Abe K, Ide T, Kinugawa S,Tsutsui H. ZBP1 protects against mtDNA-induced myocardial inflammation in failing hearts. Circ Res 132(9):1110-1126, 2023
    • <著書>

        • 筒井裕之(編集),真茅みゆき(編集):実践!心不全療養指導,メジカルビュー,2023
        • 筒井裕之:HFpEF(拡張不全), 伊藤浩 山下武志編:循環器疾患 最新の治療2022-2023, 69-74, 南江堂, 2022
        • 筒井裕之:循環器疾患 最近の動向, 福井次矢, 高木誠 小室一成編:今日の治療指針 私はこう治療している, 348-351, 医学書院, 2022
        • 筒井裕之:循環器疾患患者のみかた, 矢﨑義雄, 小室一成編:内科学 第12版, 3-5, 朝倉書店, 2022
        • 筒井裕之:循環器疾患を理解するためのポイント、矢崎義雄 監修編 新臨床内科学, 246-253,医学書院, 2020
    • <その他>

  • プロフィール

    • <所属学会>

      • 日本心不全学会
      • 日本動脈硬化学会医 ほか